The Medicines Company is a biopharmaceutical company that researches and develops therapeutics for the treatment of cardiovascular diseases.
Business Model:
Revenue: $6.1M
Employees: 51-200
The Medicines Company was acquired by
Novartis.
The acquisition happend on 2019-11-24.
Details of the transaction were not public
Address: 8 Sylvan Way
City: Parsippany
State: NJ
Zip: 07054
Country: US
The Medicines Company is a biopharmaceutical company that researches and develops therapeutics for the treatment of cardiovascular diseases.
Contact Phone:
+19732906000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/18/2000
Ticker Symbol:
MDCO
IPO Price:
$16/share
Amount Raised:
$96M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
2/2015 | Annovation BioPharma | |
4/2014 | Tenaxis Medical | |
12/2013 | Rempex Pharmaceuticals | |
8/2013 | ProFibrix | |
12/2012 | Incline Therapeutics | |
12/2009 | ApoA-I Milano | |
1/2009 | Targanta Therapeutics | |
8/2008 | Curacyte Discovery GmbH |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|